Yahoo Italia Ricerca nel Web

Risultati di ricerca

1. finance.yahoo.com › news › eli-lilly-mirikizumab-shows-promiseEli Lilly’s mirikizumab shows promise in Phase III Crohn’s...

   finance.yahoo.com › news › eli-lilly-mirikizumab-shows-promise

   • Cache

   13 ore fa · Eli Lilly has reported promising results from the Phase III VIVID-1 study of mirikizumab in treating moderately to severely active Crohn's disease. The randomised, treat-through, double-blind ...

2. it.marketscreener.com › quotazioni › azioneL'Australia vieterà le copie dei popolari farmaci per la perdita...

   it.marketscreener.com › quotazioni › azione

   • Cache

   13 ore fa · Eli Lilly and Company è uno dei gruppi farmaceutici leader a livello mondiale. Le vendite nette sono così suddivise per settore terapeutico: - endocrinologia (57,7%): prodotti per il trattamento dell'osteoporosi, del diabete e dei problemi di crescita; - oncologia (19,5%); - malattie immunologiche (11,1%); - neurologia (8,4%): principalmente farmaci utilizzati nel trattamento della ...

3. www.marketscreener.com › quote › stockEli Lilly and Company : Technically solid - MarketScreener

   www.marketscreener.com › quote › stock

   • Cache

   3 ore fa · Potential. $803.17. $900. $750. +12.06%. Eli Lilly and Company's shares display attractive technical aspects to anticipate a comeback of the underlying trend. Summary. The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

4. Immagini

   • 
   • 
   • 
   • 

   Mostra tutto

5. seekingalpha.com › news › 4109205-australia-ban-compoundedAustralia to ban compounded weight loss drugs (NYSE:LLY)

   seekingalpha.com › news › 4109205-australia-ban-compounded

   2 ore fa · Australia will ban replicas of weight loss drugs, including Novo Nordisk's (NVO) semaglutide and Eli Lilly's (LLY) tirzepatide, due to adverse events. Read more here.

6. www.aktiencheck.de › exklusiv › Artikel-Eli_Lilly_meldetEli Lilly meldet weitere Radiopharma-Zusammenarbeit -...

   www.aktiencheck.de › exklusiv › Artikel-Eli_Lilly_meldet

   • Cache

   13 ore fa · Dollar für die Kooperation und Eli Lilly gehe eine Kapitalbeteiligung am Radiopharma-Player ein, der nicht börsennotiert sei. Zudem habe Aktis Oncology den Anspruch auf Meilensteinzahlungen von ...

7. uk.marketscreener.com › quote › stockAustralia to ban knock-offs of popular weight-loss drugs Ozempic...

   uk.marketscreener.com › quote › stock

   • Cache

   13 ore fa · Australia said on Wednesday it will ban copies of drugs used for weight loss such as Ozempic and Mounjaro, arguing that so-called compounded versions are not rigorously tested and are potentially...

8. www.finanznachrichten.de › nachrichten-2024-05 › 62293260-eliEli Lilly: Nächster Radiopharma-Deal - Aktie mit neuem Rekordhoch

   www.finanznachrichten.de › nachrichten-2024-05 › 62293260-eli

   • Cache

   13 ore fa · Artikel bewerten: (0) Eli Lilly: Nächster Radiopharma-Deal - Aktie mit neuem Rekordhoch. Der Radiopharma-Markt bleibt mächtig in Bewegung. In den vergangenen Monaten haben mehrere ...